Dialogue Volume 13 Issue 3 2017 - Page 29

clearly defined role. The landscape in Ontario has evolved with the devel- opment of the narcotics monitoring system (NMS), a consolidated database of all narcotics prescriptions in Ontario, managed by the Ministry of Health and Long- Term Care. Its development has improved the under- standing of prescribing practices across the province. The College continues to advocate for a comprehensive prescription monitoring program that will provide real time access to prescribers. Following is just some of the activity underway led by system partners that will help to strengthen physician prescribing practices: Real Time Access to Patient Medication Profiles The Ministry of Health and Long-Term Care, as the guardian of prescribing information in Ontario, has committed to improving access to p atient medication profiles for prescribers. Physicians require real-time ac- cess to patient prescribing information to inform best prescribing practices. Comparative Opioid Prescription Data Health Quality Ontario (HQO) has been tasked with including opioid prescribing indictors in the existing Primary Care Practice Reports, which provide indi- vidual physicians with key measurements and feedback information to support quality improvement within their practices. Providing physicians with informa- tion about their own prescribing practices will support their efforts to prescribe opioids appropriately. HQO is also developing quality standards relating to opi- oid use disorder; opioid prescribing for chronic pain; and opioid prescribing for acute pain. The College’s Prescribing Drugs policy reflects that quality stan- dards from HQO should be considered and applied, as appropriate. Guidelines The Michael G. DeGroote National Pain Centre at McMaster University led an international team of clini- cians, researchers and patients in the development of new national clinical guidelines for the prescribing of opioids for chronic non-cancer pain. The College released a state- ment in response to the updated guidelines. Updated Medical Education Faculties of medicine and relevant national education bodies are responsible for ensuring that medical educa- tion is objective, accurate, and up-to-date with respect to the appropriate and effective prescribing of opioids. The Association of Faculties of Medicine of Canada, for example, has committed to have faculty experts review opioid education activities currently in use across Canada, and create a repository of education products that reflect best practice and provide them to all facul- ties. Various other stakeholders in medical education have also committed to undertake specific actions to evaluate and improve medical education with respect to opioids, including the Canadian Federation of Medical Students, the College of Family Physicians of Canada, and the Royal College of Physicians and Surgeons of Canada. These commitments are captured in the Joint Statement of Action to Address the Opioid Crisis. Looking Forward Through our opioid strategy, the College has identified and committed to a specific plan of action within its own area of responsibility of medical regulation, and is committed to reporting on progress. Prescribing opioids under the right conditions is critical for good patient care. Our goal is to ensure that physicians have the resources and information they need to appropriately prescribe opioids to their patients. MD ISSUE 3, 2017 DIALOGUE 29